Management of BCG non-responders with fixed dose intravesical gemcitabine in superficial transitional cell carcinoma of urinary bladder
Aims and Objectives: The incidence of bladder malignancy is increasing worldwide and the projected rise is 28% by 2010 for both sexes (WHO). Though intravesical adjuvant therapy with BCG is superior to any other immunotherapeutic/chemotherapeutic agent in reducing tumor recurrences and disease progr...
| 發表在: | Indian Journal of Urology |
|---|---|
| Main Authors: | , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Wolters Kluwer Medknow Publications
2008-01-01
|
| 主題: | |
| 在線閱讀: | http://www.indianjurol.com/article.asp?issn=0970-1591;year=2008;volume=24;issue=1;spage=44;epage=47;aulast=Mohanty |